Although EFV increases with body mass index (BMI), some ACS patients have an increased EFV but normal BMI. We here investigated the clinical characteristics of nonobese ACS patients with an increased EFV.
Introduction
Obesity is a risk factor for cardiovascular disease. However, adipose tissue distribution, rather than total body fat, has gained attention as a marker for cardiovascular risk 1) . Numerous studies have thus shown that abdominal obesity associated with an excess of visceral fat is predictive of an increased risk for coronary artery disease [2] [3] [4] . Japanese adults show a propensity for greater accumulation of visceral fat than of subcutaneous fat 5) . In addition, Japanese men have more abdominal visCopyright©2018 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.
follow-up with invasive coronary angiography was not undertaken. The study was performed in accordance with the Declaration of Helsinki and was approved by the ethics review board of Chubu Rosai Hospital. All patients provided written informed consent.
CT Image Analysis
Epicardial fat content was determined on the basis of cardiac CT scans by two experienced analysts. EFV was defined as the total amount of adipose tissue between the surface of the heart and the visceral layer of the pericardium and was measured as described previously 12) . The precise determination of the pericardium is not easy 14) . When we were unable to locate the pericardium precisely, we used a manual trace to observe the clearly determinable levels above and below the imprecise part. Then the software traced the imprecise part automatically. By performing a manual trace on as many levels as possible, we were able to decrease interobserver reliability. After confirming that the coronary artery was entirely contained within the region of interest in the volume rendering images, we determined EFV. Abdominal CT scans were also performed at the fourth to fifth lumbar levels. Visceral adipose tissue was analyzed in an image taken at the umbilicus level. Visceral fat area (VFA) was defined as intraperitoneal fat with attenuation ranging from 190 to 30 Hounsfield units and was measured with the use of dedicated software 15) .
Statistical Analysis
Categorical and continuous variables are presented as the number (percentage) of individuals and as means SD, respectively. Differences between two groups were evaluated with Student's unpaired t test or the Mann -Whitney U test for parameters with a normal or non-normal distribution, respectively, as determined with the Shapiro test. Differences among four groups were evaluated by analysis of variance (ANOVA) followed by Scheffe's test. The potential correlation of EFV with other clinical parameters was examined with Spearman's correlation coefficient by rank test. Logistic regression analysis was performed to determine whether clinical parameters were associated with ACS. A P value of 0.05 was considered statistically significant. All statistical analysis was performed with the use of StatView for Windows software (Abacus Concepts, Berkeley, CA).
Results

Baseline Characteristics of the Study Subjects
The clinical characteristics of the study patients are shown in Table 1 . Most patients with ACS were tion in epicardial fat may influence the pathogenesis of coronary atherosclerosis 9, 10) . A causal relationship between epicardial adipose tissue and non-calcified plaque was reported 11) ; furthermore, an increased epicardial fat volume (EFV) has been shown to be an independent risk factor for acute coronary syndrome (ACS) 12) . EFV tends to increase with BMI, but some individuals with ACS have an increased EFV but a normal BMI. Given that visceral fat accumulation is a major contributor to an increased risk of cardiovascular disease even in nonobese patients 13) , we have now evaluated the clinical characteristics of nonobese ACS patients with an increased EFV.
Methods
Subjects
This retrospective cohort study assessed 223 consecutive patients who were hospitalized for ACS between June 2011 and November 2014. These individuals included patients with ST-elevated myocardial infarction (STEMI) and non-STEMI patients. STEMI patients were defined as individuals presenting with ischemic chest discomfort, an elevated ST-segment on the electrocardiogram, and an increased circulating troponin-I level, whereas individuals presenting with ischemic chest discomfort and an increased troponin-I level but without ST-segment elevation were classified as non-STEMI patients. The patients underwent coronary angiography, with the culprit lesions being identified on the basis of detection of pronounced stenosis ( 90% obstruction). Coronary artery bypass graft surgery was deemed necessary for eight patients, and the remaining patients underwent percutaneous coronary intervention. All patients also underwent cardiac computed tomography (CT) during hospitalization as well as provided peripheral venous blood samples for analysis after an overnight fast. Lipid and glucose profiles were evaluated. In addition to those who underwent coronary artery bypass graft surgery (n 8), we excluded patients who died after hospitalization (n 2), who underwent implantation of a cardioverter defibrillator (n 1), who required postoperative dialysis (n 2), who did not regain consciousness after resuscitation for ventricular fibrillation (n 2), who were found to have cancer after hospitalization (n 1), or who did not undergo coronary angiography as recommended by the attending physician (n 10). A total of 197 ACS patients was thus enrolled in the study. A control group consisted of 141 consecutive outpatients suspected of having ACS but found to have no obstructing stenosis during the same period. Blood analysis, electrocardiography, and cardiac CT examination were performed to evaluate symptoms of acute chest discomfort, but cumference (r 0.30, P 0.01), serum triglyceride level (r 0.16, P 0.030), and VFA (r 0.52, P 0.01) ( Table  2 ). In the control group, EFV was significantly correlated with age (r 0.20, P 0.018), BMI (r 0.50, P 0.01), abdominal circumference (r 0.49, P 0.01), and VFA (r 0.62, P 0.01). Although EFV was positively correlated with BMI, abdominal circumference, and VFA in both groups, the correlation coefficients were greater for the control subjects than for the ACS patients. Analysis of only nonobese individuals (BMI 25 kg/m 2 ), however, revealed that the correlation coefficients between EFV and BMI, VFA were greater for the ACS patients than for the control subjects and that EFV was significantly correlated with abdominal circumference and serum triglyceride level in ACS patients (r 0.26, P 0.017; r 0.22, P 0.023, respectively) but not in control subjects.
Factors Independently Associated with ACS in Nonobese Individuals
Logistic regression analysis was performed to assess the independent association of clinical parameters with ACS among nonobese subjects ( Table 3 ). An EFV of 100 mL (the cutoff value in our previous study 12) ), a serum HDL-cholesterol concentration of male and current smokers. BMI was 24.6 3.6 and 24.0 4.2 kg/m 2 for the ACS and control groups, respectively, with the difference between the two groups not being statistically significant. Patients with ACS had lower serum triglyceride and high density lipoprotein (HDL) -cholesterol levels compared with the control subjects. The culprit vessels for ACS included the right coronary artery in 68 patients, left main coronary trunk in 2 patients, left anterior descending coronary artery in 102 patients, and left circumflex coronary artery in 25 patients. The average duration of hospitalization for the ACS patients was 13.2 5.6 days. EFV was significantly increased in the ACS group compared with the control group (120 47 versus 95 45 mL, P 0.01). Examination of only nonobese individuals (BMI 25 kg/m 2 ), patients with ACS had larger abdominal circumference, and increased VFA and EFV (90 39 versus 78 37 cm 2 , P 0.04; 107 47 versus 86 35 mL, P 0.01, respectively) compared with the control subjects.
Relation between EFV and Other Clinical Parameters
In the ACS group, EFV was significantly correlated with BMI (r 0.41, P 0.01), abdominal cir- Abbreviations not defined previously: r, correlation coefficient; Hs-CRP, high-sensitivity C-reactive protein.
pared with nonobese control subjects, and their EFV was positively correlated with serum triglyceride level and abdominal circumference. Third, EFV was independently associated with ACS in nonobese individuals. These findings suggest that individuals with increased insulin resistance despite a normal BMI may have an increased EFV and associated increased risk for developing ACS. Complications of obesity are more related to visceral adiposity than to excess body fat per se, with an increased abdominal adipose tissue content having been shown to be associated with adverse changes in risk factors for cardiovascular disease even after adjustment for BMI 17) . Insulin resistance is associated with elevated triglyceride levels, high blood pressure, and type 2 diabetes as well as with reduced levels of HDL-cholesterol 18) . It has also been shown to predict cardiovascular disease events 19) . Although insulin resistance is correlated with BMI, normal-weight individuals may also be insulin resistant, suggesting that overall adiposity is not its sole determinant 20) . Indeed, insulin resistance is more strongly associated with abdominal obesity than with BMI. Waist circumference is often measured as a marker of abdominal obesity, and we found that EFV was positively correlated with abdominal circumference in nonobese ACS patients. Measurement of abdominal girth may, therefore, be useful for ACS risk assessment even in nonobese individuals.
Pericardial fat is a local deposit of visceral fat surrounding the heart and coronary arteries that may exacerbate vessel wall inflammation and promote the progression of atherosclerosis via outside-to-inside signaling 21, 22) . The abundance of pericardial fat was found to be increased in patients with coronary atherosclerosis including nonobese individuals 23) . Ectopic deposition of fat in the liver or muscle tissue is thought to be an important factor in the development of insulin resis-40 mg/dL and current smoking were found to be independently associated with ACS (odds ratio 2.01, P 0.021; odds ratio 2.67, P 0.014; and odds ratio 3.16, P 0.01, respectively). A VFA of 100 cm 2 was not a significant factor. Epicardial fat was thus more strongly associated with ACS than was abdominal visceral fat in nonobese individuals.
Clinical Characteristics of Nonobese ACS Patients with an Increased EFV
Given that we found that EFV was positively correlated with BMI in both ACS and control groups (Table 2, Fig. 1 ) and that obesity in Japan is defined as a BMI of 25 kg/m 2 16) , we divided the ACS patients into four groups on the basis of mean EFV (120 mL) and the BMI cutoff for obesity (25 kg/m 2 ): nonobese with an above-average EFV (group ), nonobese with a below-average EFV (group ), obese with an above-average EFV (group ), and obese with a belowaverage EFV (group ). Group comprised 30 patients (age of 74 10 years, 73% men) with an abdominal VFA of 114 42 cm 2 . A significant correlation between EFV and abdominal VFA was apparent among these patients (r 0.23, P 0.031), 7 (23%) of whom met the diagnostic criteria for metabolic syndrome. Moreover, the patients in group were older (P 0.01) and tended to have a higher homeostasis model assessment -insulin resistance value (5.5 3.8, P 0.091) compared with those in the other three groups ( Table 4) .
Discussion
The principal findings of our study are threefold. First, nonobese ACS patients with an increased EFV were elderly and tended to show increased insulin resistance compared with other ACS patients. Second, nonobese patients with ACS had an increased EFV com- Accumulation of excess ectopic fat is an important risk factor for many diseases -including hypertension, type 2 diabetes, dyslipidemia, and atherosclerosis -as a result of the associated production of angiotensinogen and angiotensin , activation of inflammation, and reduced levels of adiponectin 27) . Adipocytance 24, 25) . Moreover, an increased bioactive lipid content in human subcutaneous and epicardial fat tissue correlates with insulin resistance 26) . Insulin resistance in adipose tissue manifests as impairment of the stimulatory and inhibitory effects of insulin on glucose transport and lipolysis, respectively. (Table 1) . Furthermore, triglyceride/HDL ratio was not an independent associated factor (odds ratio 1.02, P 0.824) for ACS in nonobese subjects. It might be due to the high diabetic prevalence in the control group. Even in nondiabetic patients, insulin resistance progresses in parallel with heart failure and impaired functional capacity of the cardiovascular system 30) . Second, nonobese ACS patients had an increased serum concentration of brain natriuretic peptide compared with nonobese controls subjects ( Table 1 ), suggesting that some of these ACS patients may have developed insulin resistance in association with complicated heart failure. Third, the cutoff of VFA was 100 cm 2 for logistic regression analysis, in accordance with the diagnostic criteria of visceral fat obesity in Japan 16) . However, Japanese have a greater amount of abdominal visceral fat relative to abdominal subcutaneous fat compared with Caucasians 5) . Fourth, the study population was relatively small and was composed exclusively of Japanese subjects. More research is thus required to explore the implications of our findings for clinical practice.
Conclusion
We found that nonobese ACS patients with an increased EFV were elderly and tended to manifest insulin resistance. EFV was also identified as an independent related factor for ACS in nonobese individuals. In addition, among nonobese individuals, EFV was positively correlated with abdominal circumference in ACS patients but not in control subjects. Our tokines secreted from perivascular adipocytes have been proposed to inhibit insulin signaling via the phosphatidylinositol 3-kinase pathway in vascular endothelial cells and thereby to leave unopposed the vasoconstrictor effect of endothelin-1 22) . Reduced insulin-mediated enhancement of muscle nutritive blood flow contributes to insulin resistance. We have now found that insulin resistance tended to be increased in nonobese ACS patients with an increased EFV, suggesting that accumulation of epicardial fat may be related to insulin resistance in nonobese ACS patients.
In this study, the number of current smokers was increased in the ACS group. The association between EFV and smoking has not been elucidated. However, epicardial adipose tissue levels of TNF-and IL-6 were significantly elevated in current smokers when compared with never smokers and former smokers 28) , which supports the mechanism that epicardial adipose tissue in smokers could contribute to the pathogenesis of adverse effects of tobacco smoking.
There are several limitations to the present study. First, some biomarkers related to insulin resistance, such as fasting plasma glucose and insulin concentrations, were not measured in the control subjects because not all of them had fasted before visiting the hospital. Comparison of insulin resistance between ACS patients and the control subjects was thus not possible. The ratio of triglyceride to HDL-cholesterol has been proposed as a surrogate marker of insulin resistance 29) . In this study subject, there was no significant difference in triglyceride/HDL ratio between two groups Data are presented as means SD or number (%) of patients as indicated. P values were determined by ANOVA followed by Scheffe's test. Abbreviations not defined previously: HOMA-IR, homeostasis model assessment -insulin resistance. Group , above-average EFV and nonobese; group : below-average EFV and nonobese; group , above-average EFV and obese; group , below-average EFV and obese.
